Lumibird launches AI-driven diagnostic aid platform for dry eye disease
Click Here to Manage Email Alerts
Lumibird Medical announced the launch of C.DIAG, a diagnostic aid platform that uses AI algorithms to help health care providers diagnose patients with dry eye disease.
According to company press release, the new platform is the third component of the company’s C.SUITE, which includes products to help treat dry eye disease and educate patients about the condition.
“C.DIAG is an automated diagnostic aid platform, the most complete on the market, integrating multiple exams as transillumination meibography and an autofocus HD camera for unrivaled image quality and automatic, accurate and reproducible results,” Delphine Southon, Lumibird’s dry eye product manager, said in the release.
“DED symptoms are often misunderstood. This multifactorial pathology is often underdiagnosed and underestimated,” Jean-Marc Gendre, the company’s CEO, said in the release. “We are convinced that this new innovative C.SUITE offer is a premium diagnosis and treatment solution [for] health care professionals confronted with the daily challenge of dry eye management.”
Read more about
Click Here to Manage Email Alerts